A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. "These patent allowances are a critical component
As previously announced, Translational Drug Development, LLC (TD2) will conduct the study. Ascites fluid accumulates in the abdomen and is usually associated with the development of advanced pancreatic
Research will be conducted in collaboration with Dr. Zeljko Vujaskovic, Director of the Division of Translational Radiation Sciences at the University of Maryland School of Medicine. Prostate cancer
The research funded by this award will be conducted in collaboration with the University of British Columbia, the Vancouver Prostate Centre and the B.C. Cancer Agency. This funding
These patients are currently being treated by commercially-available Factor VIIa, with estimated 2013 worldwide sales of $1.7 billion. Factor VIIa-CTP already obtained orphan status in the U.S. earlier
Fluphenazine decanoate injection is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine decanoate injection
Currently, the company is carrying out a randomized, double-blind, placebo-controlled Phase III clinical trial (VALOR), in patients with first relapsed or refractory acute myeloid leukemia (AML). A PIP
This USPTO issuance, combined with a similar success for a Chinese patent (ZL 200880124132.8) provides a solid foundation and protection for the company’s leading siRNA therapeutic project under
A new drug application was filed for the nonsteroidal anti-inflammatory drug (NSAID) with the Republic of Lebanon Ministry of Public Health (MOPH). ZORVOLEX was approved by the U.S.
The Company’s strategic research plan is designed to establish a series of inflammation assays and models with the goal of developing a hemp-extract profiling platform. This platform will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.